Zonisamide
E2090-E044-310
Phase 3 small_molecule completed
Quick answer
Zonisamide for Epilepsy is a Phase 3 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eisai Co.,
- Indication
- Epilepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed